NO960534D0 - Amidinderivater med nitrogenoksydsynteseaktiviteter - Google Patents

Amidinderivater med nitrogenoksydsynteseaktiviteter

Info

Publication number
NO960534D0
NO960534D0 NO960534A NO960534A NO960534D0 NO 960534 D0 NO960534 D0 NO 960534D0 NO 960534 A NO960534 A NO 960534A NO 960534 A NO960534 A NO 960534A NO 960534 D0 NO960534 D0 NO 960534D0
Authority
NO
Norway
Prior art keywords
nitric oxide
oxide synthesis
amidine derivatives
synthesis activities
activities
Prior art date
Application number
NO960534A
Other languages
English (en)
Other versions
NO960534L (no
NO306459B1 (no
Inventor
Robert James Gentile
Robert John Murray
James Edwin Macdonald
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939316806A external-priority patent/GB9316806D0/en
Priority claimed from GB939319835A external-priority patent/GB9319835D0/en
Priority claimed from GB939325410A external-priority patent/GB9325410D0/en
Priority claimed from GB9401580A external-priority patent/GB9401580D0/en
Priority claimed from GB9411700A external-priority patent/GB9411700D0/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO960534D0 publication Critical patent/NO960534D0/no
Publication of NO960534L publication Critical patent/NO960534L/no
Publication of NO306459B1 publication Critical patent/NO306459B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
NO960534A 1993-08-12 1996-02-09 Amidinderivater med nitrogenoksydsyntetaseaktiviteter, farmasöytisk preparat og anvendelse av amidinderivatene NO306459B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB939316806A GB9316806D0 (en) 1993-08-12 1993-08-12 Pharmaceutically active compounds
GB939319835A GB9319835D0 (en) 1993-09-25 1993-09-25 Pharmaceutically active compounds
GB939325410A GB9325410D0 (en) 1993-12-11 1993-12-11 Pharmaceutically active compounds
GB9401580A GB9401580D0 (en) 1994-01-27 1994-01-27 Pharmaceutically active compounds
GB9411700A GB9411700D0 (en) 1994-06-10 1994-06-10 Pharmceutically active compounds
PCT/GB1994/001767 WO1995005363A1 (en) 1993-08-12 1994-08-12 Amidine derivatives with nitric oxide synthetase activities

Publications (3)

Publication Number Publication Date
NO960534D0 true NO960534D0 (no) 1996-02-09
NO960534L NO960534L (no) 1996-04-11
NO306459B1 NO306459B1 (no) 1999-11-08

Family

ID=27517202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960534A NO306459B1 (no) 1993-08-12 1996-02-09 Amidinderivater med nitrogenoksydsyntetaseaktiviteter, farmasöytisk preparat og anvendelse av amidinderivatene

Country Status (18)

Country Link
US (2) US5807885A (no)
EP (1) EP0713483B1 (no)
JP (1) JPH09501918A (no)
AT (1) ATE231126T1 (no)
AU (1) AU682381B2 (no)
BR (1) BR9407515A (no)
CA (1) CA2169280A1 (no)
CZ (1) CZ29996A3 (no)
DE (1) DE69432019T2 (no)
FI (1) FI960628A0 (no)
HU (1) HUT75876A (no)
IL (1) IL110643A (no)
NO (1) NO306459B1 (no)
NZ (1) NZ269571A (no)
PL (1) PL180081B1 (no)
RU (1) RU2130017C1 (no)
SK (1) SK16396A3 (no)
WO (1) WO1995005363A1 (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2136661C1 (ru) * 1993-10-21 1999-09-10 Джи Ди Сирл энд Ко. Амидинопроизводные, их применение и фармацевтическая композиция
AU682768B2 (en) * 1994-05-07 1997-10-16 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
DK0758890T3 (da) 1994-05-11 2005-04-18 Jes Olesen Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
WO1996021445A1 (en) * 1995-01-13 1996-07-18 The General Hospital Corporation Methods of inhibiting neurodegenerative diseases
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
WO1996033175A1 (en) * 1995-04-20 1996-10-24 G.D. Searle & Co. Cyclic amidino agents useful as nitric oxide synthase inhibitors
BR9509297A (pt) * 1995-08-10 1998-07-07 Astra Ab Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto
WO1997009982A1 (fr) * 1995-09-14 1997-03-20 Nippon Kayaku Kabushiki Kaisha Inhibiteur de monoxyde d'azote synthetase qui contient des 2-aminopyridines en tant qu'ingredient actif
TW458978B (en) * 1995-11-07 2001-10-11 Astra Ab Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
US6140322A (en) * 1995-11-07 2000-10-31 Astra Aktiebolag Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
WO1997046515A1 (fr) * 1996-06-04 1997-12-11 Chugai Seiyaku Kabushiki Kaisha Benzenes substitues ne presentant pas d'effets inhibiteurs
US5929085A (en) * 1996-11-06 1999-07-27 Astra Aktiebolag Amidine and isothiourea derivatives, compositions containing them and their use as inhibitors of nitric oxide synthase
PL334304A1 (en) 1996-12-24 2000-02-14 Chugai Pharmaceutical Co Ltd Derivatives of aromatic amines acting as nos inhibitors
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US6335445B1 (en) * 1997-03-24 2002-01-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
AU8330898A (en) * 1997-05-02 1998-11-27 Schering Aktiengesellschaft Substituted heterocycles and their use in medicaments
US6166030A (en) * 1997-05-05 2000-12-26 Astra Aktiebolag Compounds
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
AU726861B2 (en) 1997-07-03 2000-11-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
TW460460B (en) * 1997-11-04 2001-10-21 Chugai Pharmaceutical Co Ltd Heterocyclic compounds having NOS inhibitory activities
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
US6489323B1 (en) 1998-06-10 2002-12-03 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
FR2784678B1 (fr) * 1998-09-23 2002-11-29 Sod Conseils Rech Applic Nouveaux derives de n-(iminomethyl)amines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US7115557B2 (en) 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
SE9803710L (sv) 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
SK4782001A3 (en) 1998-10-08 2001-11-06 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
FR2801053B1 (fr) * 1999-11-16 2004-06-25 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation et leur application a titre de medicaments
SE9904676D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
SE9904677D0 (sv) * 1999-12-20 1999-12-20 Astra Ab Novel compounds
KR20010068667A (ko) * 2000-01-07 2001-07-23 박선호 신규 알리파틱아마이드계 항종양 물질
WO2001068585A1 (fr) * 2000-03-14 2001-09-20 Fujisawa Pharmaceutical Co., Ltd. Nouveaux composes amides
JP2003527391A (ja) * 2000-03-16 2003-09-16 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・（エス．セー．エール．アー．エス） 新規なリポ酸の複素環又はベンゼン誘導体、その製造方法及びその医薬としての使用
FR2812198B1 (fr) * 2000-07-28 2008-07-18 Sod Conseils Rech Applic DERIVES D'AMIDINES INHIBITEURS DE PHOSPHATASES cdc25
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
US6770636B2 (en) * 2000-08-18 2004-08-03 Boehringer Ingelheim Pharma Kg Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines
DZ3415A1 (fr) 2000-08-31 2002-03-07 Chiron Corp Guanidinobenzamides comme mc4-r agonistes.
AU2001282829A1 (en) * 2000-09-05 2002-03-22 Astrazeneca Ab Amidine derivatives which are inhibitors of nitric oxide synthase
UA75093C2 (en) 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
EP1385823B1 (en) 2001-04-09 2006-12-13 Chiron Corporation Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
US6514960B1 (en) 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
DE10162114A1 (de) * 2001-12-12 2003-06-26 Schering Ag Neue Amidin-Derivate und deren Verwendung in Arzneimitteln
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
WO2003072056A2 (en) * 2002-02-25 2003-09-04 Chiron Corporation Intranasal administration of mc4-r agonists
JP2005531583A (ja) 2002-05-23 2005-10-20 カイロン コーポレイション 置換キナゾリノン化合物
FR2842808B1 (fr) * 2002-07-25 2004-09-10 Sod Conseils Rech Applic Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
JP2007501861A (ja) * 2003-05-23 2007-02-01 カイロン コーポレイション Ｍｃ４−ｒアゴニストとしてのグアニジノ置換キナゾリノン化合物
MXPA06005736A (es) * 2003-11-19 2006-12-14 Chiron Corp Compuestos de quinazolinona con bioacumulacion reducida.
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
KR101238525B1 (ko) 2004-12-31 2013-02-28 레디 유에스 테라퓨틱스 인코포레이티드 Ｃｅｔｐ 저해제로서의 신규 벤질아민 유도체
US7914705B2 (en) * 2005-01-10 2011-03-29 Robert Eliot Sisson Flowable electrical conductive liquid
US9199967B2 (en) 2011-08-18 2015-12-01 Dr. Reddy's Laboratories Ltd. Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors
CA2850022C (en) 2011-09-27 2018-05-01 Dr. Reddy's Laboratories, Ltd. 5 - benzylaminomethyl - 6 - aminopyrazolo [3,4-b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis
RU2480452C1 (ru) * 2012-01-11 2013-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА Минздрава России) Способ получения n-4-нитрофенилбензамидина
US8735606B2 (en) * 2012-08-30 2014-05-27 Northwestern University Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors
EP2740474A1 (en) 2012-12-05 2014-06-11 Instituto Europeo di Oncologia S.r.l. Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
WO2016156396A1 (en) 2015-03-30 2016-10-06 University Of Innsbruck Diphenethylamine derivatives which are inter alia useful as analgesics and methods for their production
RU2684117C1 (ru) * 2018-10-29 2019-04-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Способ получения N-(нафталин-2-ил)бензамидина
RU2694263C1 (ru) * 2019-02-14 2019-07-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Анальгезирующее и противовоспалительное средство с противомикробной активностью
US20220280644A1 (en) * 2019-08-09 2022-09-08 University Of Utah Research Foundation "TRPswitch" - A STEP FUNCTION CHEMO-OPTOGENETIC LIGAND

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299081A (en) * 1963-09-13 1967-01-17 Merck & Co Inc Chemical processes for preparing nu-substituted amidines
NL135043C (no) * 1963-10-11
GB1188956A (en) * 1967-07-14 1970-04-22 Delalande Sa N-Substituted Aromatic Amidines and process for obtaining same
GB1180629A (en) * 1967-07-14 1970-02-04 Delalande Sa Di-Amidines derived from Aromatic Diamines and process for obtaining same
US3669974A (en) * 1971-03-25 1972-06-13 Usv Pharma Corp N,n1-disubstituted benzamidines
DE2321330A1 (de) * 1973-04-27 1974-11-07 Bayer Ag Azolyl-amidine, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
US3988474A (en) * 1974-11-06 1976-10-26 The Dow Chemical Company N,N'-dialkyl-halobenzamidines as antidepressants
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
JPS5857357A (ja) * 1981-09-30 1983-04-05 Daikin Ind Ltd 含フツ素アミジン類及びその製造方法
IT1211138B (it) * 1981-12-01 1989-09-29 Ausonia Farma Srl Composto antiipertensivo procedimento per la sua preparazione e relative composizioni farmaceutiche.
EP0097463A3 (en) * 1982-06-16 1985-05-15 Beecham Group Plc Amidine derivatives
JPS60130561A (ja) * 1983-12-16 1985-07-12 Torii Yakuhin Kk アミジン誘導体およびそれを含む強心剤
US4634705A (en) * 1984-06-06 1987-01-06 Abbott Laboratories Adrenergic amidines
IE62023B1 (en) * 1989-01-02 1994-12-14 Boots Co Plc Therapeutic agents
JPH02229147A (ja) * 1989-03-03 1990-09-11 Nissan Chem Ind Ltd フッ素含有化合物
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof
US5132453A (en) * 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5286752A (en) * 1991-09-10 1994-02-15 Sterling Winthrop Inc. Antiarrhythmic diarylamidines
ATE191847T1 (de) * 1991-12-16 2000-05-15 Univ Washington Verwendung von aminoguamidin zur herstellung eines arzneimittels zur unterdrückung der stickoxidbildung
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
US5266594A (en) * 1992-05-12 1993-11-30 Dawson Valina L Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
WO1994012797A1 (en) * 1992-11-23 1994-06-09 Dry Dock Industries, Inc. Anchoring retainer for threaded fasteners
US5362747A (en) * 1992-11-25 1994-11-08 Abbott Laboratories 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase
IL107771A0 (en) * 1992-11-27 1994-02-27 Wellcome Found Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation
AU6286294A (en) * 1993-03-23 1994-10-11 Astra Aktiebolag Guanidine derivatives useful in therapy

Also Published As

Publication number Publication date
IL110643A0 (en) 1994-11-11
NZ269571A (en) 1996-11-26
CA2169280A1 (en) 1995-02-23
BR9407515A (pt) 1997-01-07
HU9600310D0 (en) 1996-04-29
SK16396A3 (en) 1996-09-04
JPH09501918A (ja) 1997-02-25
NO960534L (no) 1996-04-11
EP0713483A1 (en) 1996-05-29
US6030985A (en) 2000-02-29
ATE231126T1 (de) 2003-02-15
US5807885A (en) 1998-09-15
EP0713483B1 (en) 2003-01-15
AU682381B2 (en) 1997-10-02
PL180081B1 (pl) 2000-12-29
CZ29996A3 (en) 1996-09-11
HUT75876A (en) 1997-05-28
RU2130017C1 (ru) 1999-05-10
DE69432019T2 (de) 2003-11-27
FI960628A (fi) 1996-02-12
DE69432019D1 (de) 2003-02-20
FI960628A0 (fi) 1996-02-12
AU7387594A (en) 1995-03-14
PL312961A1 (en) 1996-05-27
WO1995005363A1 (en) 1995-02-23
NO306459B1 (no) 1999-11-08
IL110643A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
NO960534D0 (no) Amidinderivater med nitrogenoksydsynteseaktiviteter
NZ335981A (en) Ketobenzamides as calpain inhibitors
IL119462A (en) 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines
ZA952095B (en) Inhibition of hair growth
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
BG101110A (en) Substituted pyrimidine compounds and their application
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
AP2001002318A0 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
BG106450A (en) Use of retigabin for treating neuropathic pain
TR199900308T2 (xx) Tiyenopirimidinler
ES8407491A1 (es) Un procedimiento para la preparacion de nuevos benzopiranos. como divisional de la solicitud de patente n 515.921no de 23 de septiembre de 1982.
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DK0920426T3 (da) Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
ATE275143T1 (de) Verbindungen
NO20026246D0 (no) 2-aminoalkyl-tieno[2,3-d]pyrimidiner
DE69432801D1 (de) Verbindungen die als antiproliferierende mittel und garft inhibitoren verwendbar sind
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
MD980248A (ro) Derivaţi ai carbolinei
UA41200A (uk) Спосіб консервативного лікування остеоартрозу

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003